We don’t know when (exactly) Lilly will announce the FDA’s baricitinib decision, but watch out for the looming pricing squabble
Sometime in the next few days, the FDA will be right on the PDUFA decision deadline for baricitinib. We just don’t know which day.
For some reason, Eli Lilly $LLY has decided to keep the deadline under wraps, as confirmed yesterday by a spokesperson for the company. It could be tonight, ahead of a long holiday weekend in the US. It could be tomorrow. They could even wait until Monday, after the decision is formal, to roll out their announcement.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.